Winner Medical(SZ:300888) Xin Lang Zheng Quan·2025-09-17 14:25Core Viewpoint - The event celebrated the fifth anniversary of the company, highlighting its achievements and future growth plans under the theme "Brand Upward, Steady Growth" [1] Group 1: Company Achievements - The company has achieved a compound annual growth rate of approximately 15% in revenue over the past five years, with projected revenue reaching 9 billion yuan in 2024 [2] - The company has maintained resilience through various economic cycles, with its medical and consumer goods sectors showing strong growth [2] - Cumulatively, the company has distributed 2.88 billion yuan in cash dividends and repurchased shares worth 690 million yuan, representing 100.3% of the net funds raised during its IPO [3] Group 2: ESG Strategy - The company released its ESG strategy, emphasizing its commitment to sustainable development and social responsibility [5] - The company has set carbon peak and carbon neutrality goals, focusing on green product development and responsible supply chains [5] - The company has received an A rating in the Wind ESG assessment for 2025, reflecting its governance and environmental efforts [5] Group 3: Future Outlook - The company aims to continue innovation and global expansion, leveraging research and development to enhance its product offerings [8] - The company plans to strengthen its position in high-growth areas such as advanced wound management and green operating rooms [7] - The company envisions becoming a global leader in high-quality products, contributing to the global healthcare sector [8]